These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue. Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107 [TBL] [Abstract][Full Text] [Related]
6. [Age-related dynamics of the contents of matrix metalloproteinases (MMP-1, -2, -3, -9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -4) in blood plasma of residents of the European part of the Arctic zone of the Russian Federation.]. Kim LB; Russkih GS; Putyatina AN; Tsypysheva OB Adv Gerontol; 2018; 31(2):223-230. PubMed ID: 30080329 [TBL] [Abstract][Full Text] [Related]
7. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia. Lorenzl S; Buerger K; Hampel H; Beal MF Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439 [TBL] [Abstract][Full Text] [Related]
8. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios. Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Tayebjee MH; Nadar S; Blann AD; Gareth Beevers D; MacFadyen RJ; Lip GY Am J Hypertens; 2004 Sep; 17(9):764-9. PubMed ID: 15363817 [TBL] [Abstract][Full Text] [Related]
11. Behaviour of the plasma concentration of gelatinases and their tissue inhibitors in subjects with venous leg ulcers. Caimi G; Ferrara F; Montana M; Muratori I; Amato C; Canino B; Lo Presti R; Hopps E Clin Hemorheol Microcirc; 2015; 60(3):309-16. PubMed ID: 25159491 [TBL] [Abstract][Full Text] [Related]
12. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454 [TBL] [Abstract][Full Text] [Related]
13. Imbalance between matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) contributes to bladder compliance changes in rabbits with partial bladder outlet obstruction (PBOO). Yang L; Liu R; Wang X; He D BJU Int; 2013 Aug; 112(4):E391-7. PubMed ID: 23305285 [TBL] [Abstract][Full Text] [Related]
14. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605 [TBL] [Abstract][Full Text] [Related]
15. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response. Kasahara A; Hayashi N; Mochizuki K; Oshita M; Katayama K; Kato M; Masuzawa M; Yoshihara H; Naito M; Miyamoto T; Inoue A; Asai A; Hijioka T; Fusamoto H; Kamada T J Hepatol; 1997 Mar; 26(3):574-83. PubMed ID: 9075665 [TBL] [Abstract][Full Text] [Related]
17. Imbalances in tissue inhibitors of metalloproteinases differentiate choroidal neovascularization from geographic atrophy. Krogh Nielsen M; Subhi Y; Rue Molbech C; Nilsson LL; Nissen MH; Sørensen TL Acta Ophthalmol; 2019 Feb; 97(1):84-90. PubMed ID: 30288950 [TBL] [Abstract][Full Text] [Related]
18. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats]. Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283 [TBL] [Abstract][Full Text] [Related]
19. Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors. Tedeschi A; Asero R; Lorini M; Marzano AV; Cugno M Clin Exp Allergy; 2010 Jun; 40(6):875-81. PubMed ID: 20214668 [TBL] [Abstract][Full Text] [Related]
20. Purified human chondroitin-4-sulfate reduced MMP/TIMP imbalance induced by iron plus ascorbate in human fibroblast cultures. Campo GM; Avenoso A; Campo S; D'Ascola A; Ferlazzo AM; Samà D; Calatroni A Cell Biol Int; 2006 Jan; 30(1):21-30. PubMed ID: 16275145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]